Table 4.
Variable | Univariate |
Multivariate |
||||
---|---|---|---|---|---|---|
HRa | 95% CI | p-valueb | HRa | 95% CI | p-valueb | |
Age (>65 vs ≤65) | 0.998 | 0.993–1.004 | 0.606 | |||
Gender | 1.454 | 0.952–2.219 | 0.083 | |||
Grade | 1.342 | 0.923–1.951 | 0.124 | |||
Stage | 1.516 | 1.200–1.915 | <0.001 | 1.33 | 0.927–1.908 | 0.122 |
T | 1.311 | 1.028–1.672 | 0.029 | 1.075 | 0.778–1.485 | 0.661 |
M | 1.751 | 0.882–3.475 | 0.109 | |||
N | 1.268 | 1.065–1.510 | 0.008 | 1.134 | 0.899–1.430 | 0.288 |
Risk score | 2.949 | 1.720–5.055 | <0.001 | 3.283 | 1.866–5.778 | <0.001 |
m6A, N6-methyladenosine; STAD, stomach adenocarcinoma; HR, hazard ratio; CI, confidence interval; T, N, M, tumor, node, metastasis.
aValues >1.0 indicate that expression is positively associated with poor survival.
bLikelihood ratio test p-value; significant values <0.05.